EXG™ 5-Lead Wearable ECG — Continuous Rhythm Monitoring with Optimized P-Wave & QRS Morphology

EXG™ 5-Lead Wearable ECG — Continuous Rhythm Monitoring with Optimized P-Wave & QRS Morphology

Brand: Heart Medical Store

Continuous rhythm monitoring — with shape optimized for cleaner interpretation The EXG™ 5-Lead Wearable ECG is the platform's rhythm-monitoring configuration. Designed for continuous surveillance across multi-day hospital stays, its shape optimizes P-wave and QRS morphology to make rhythm interpretation faster and easier. And because it wears for up to three days at a time, most patients need only two applications across an average 5.5-day hospital stay. Now available through Heart Medical for U.S. hospitals and cath labs. Why the 5-Lead configuration matters for rhythm monitoring Continuous rhythm monitoring across medical/surgical floors, ICU beds, and cath lab recovery bays is often disrupted by the operational cost of frequent electrode re-application — nurse time, patient discomfort, workflow interruption, and gaps in coverage during changeovers. The EXG™ 5-Lead solves this in two ways: 3-day continuous wear — tolerates diaphoresis and showering. Only 2 applications needed per average 5.5-day hospital stay. No re-attachment cycles. Shape-optimized signal — the electrode geometry is designed specifically to enhance P-wave and QRS morphology, making arrhythmia interpretation more reliable at the bedside and downstream in the read. Key features — 5-Lead configuration Continuous rhythm monitoring for multi-day surveillance P-wave and QRS morphology optimization — shape designed for rhythm interpretation clarity 3-day continuous wear — tolerates diaphoresis and showering Only 2 applications per average 5.5-day hospital stay — reduces nurse time and workflow disruption Single-cable design — uses the same adapter as the EXG™ 12-Lead and other configurations Rapid application — quick to place, easy to reposition if needed Radiolucent — supports uninterrupted monitoring during imaging in cath lab settings Disposable, per-patient — single-use consumable Universal compatibility — one cable fits any standard ECG monitor Clinical applications Medical/surgical floor continuous cardiac monitoring for stroke, post-op, and arrhythmia workup patients ICU and critical care continuous rhythm surveillance Cath lab recovery bays — peri-procedural rhythm monitoring Telemetry step-down units — continuous rhythm through the transition from ICU to floor Long-duration monitoring workflows where re-application cycles disrupt care Certifications and compliance Certified for professional medical use: FDA-Registered, AHA-Compliant & ISO-13485 Certified. About C-Booth Innovations EXG™ is manufactured by C-Booth Innovations, a Carlsbad, California medical-technology company founded in 2017 by two emergency room physicians. Explore other configurations The 5-Lead is the rhythm-monitoring configuration of the EXG™ platform. For diagnostic 12-Lead ECG or specialty views, see the other configurations: EXG™ 12-Lead (Flagship) — continuous diagnostic 12-Lead monitoring; the primary configuration EXG™ 3-Lead (Reversible) — Right-sided and Posterior visualization for MI evaluation EXG™ 4-Lead (4-Electrode) — EMS rate & rhythm monitoring See the full platform at the EXG™ Wearable ECG Platform collection page. Purchase and configuration workflow Request a scoped quote. Share your program's monthly rhythm-monitoring volume and existing ECG monitor infrastructure. Configuration walkthrough. Confirm 5-Lead is the right fit; some programs also carry 12-Lead for diagnostic ECG. Deployment planning. Coordinate with your biomed / clinical engineering team on integration. Standing-order supply. EXG™ 5-Lead is disposable per-patient — predictable-volume programs benefit from standing-order setup. Request a Quote → or call +1 (833) 409-4600. Our team responds within one business day.

Variants (1)
  • Default Title — 0.00 USD — In stock

How AI sees this product

The more complete this product's details, the more confidently AI assistants can understand and recommend it.

58%